How to treat pancreatic cancer recurrence after 5 years

How to treat 5-year recurrence of pancreatic cancer? In clinical practice, chemotherapy is often used as the main treatment for postoperative recurrence of pancreatic cancer. Generally speaking, there is no chance of reoperation for postoperative recurrence of pancreatic cancer, but mucinous cystadenocarcinoma is better than ductal adenocarcinoma. If the patient's general condition is still good, further evaluation can be conducted to determine whether reoperation is possible.

Chemotherapy is the main method for treating recurrent pancreatic cancer after surgery. However, due to the side effects of chemotherapy and its insensitivity to pancreatic cancer, the long-term efficacy of chemotherapy for recurrent pancreatic cancer after surgery is not ideal.
Multi-cell biological therapy has a fine division of labor and is more effective in clinical anti-cancer. Multi-cell therapy (DC+CIK cell therapy) has become an important part of tumor treatment in the 21st century. More importantly, on the basis of DC+CIK cell therapy, NK cells, T cells, and CD3AK cells have been developed, expanding from the original 2 types of cells to 5 types of cells, becoming an upgraded version of biological therapy. Compared with "DC+CIK cell therapy", "multi-cell therapy" further improves the tumor growth environment and inhibits tumor metastasis and spread.